Navi Mumbai: Navi Mumbai Municipal Corporation (NMMC) on Thursday inaugurated an advanced microbiology laboratory at the ...

Files Quarterly Report Highlighting Broad-Spectrum Antiviral Candidate NV-387. NanoViricides, Inc. (NYSE American: NNVC) filed its Form 10-Q for the quarter ended Sept. 30, 2025, and detailed progress ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today announced the closing of its previously announced securities purchase ...

The person was infected with a strain that has previously been reported in animals but never before in humans. ..

With the onset of winter and rising flu rates in the kingdom, warnings increase about the spread of seasonal respiratory ...

Vermont added only 9 positive flu tests in Friday’s report, but those numbers will increase. Health officials are suggesting ...

How can we monitor the cross-species transmission of avian flu? The answer is FluWarning, a digital system that reports ...

Merck said on Monday it expects a commercial opportunity exceeding $5 billion from Cidara Therapeutics' experimental flu drug ...

A mutated strain of influenza A, H3N2 subclade K, is surging worldwide, sparking concerns about a severe flu season in the ...

Outcomes validate the company’s PTAP platform as a foundation for a rapid, adaptable antiviral modality across animal and ...